Loading page content…
Loading page content…
Loading contract search results…
Loading contract details…
| Source: | Contracts Finder |
| Notice Type: | Award notice |
| Buyer: | NHS England |
| Main Category: | Services |
| Procurement Method: | Negotiated procedure without prior publication (above threshold) |
| Tender Status: | Closed |
| Estimated Value (ex. VAT): | £3,891,000 |
| Release Date: | 28 November 2024 |
| Application Deadline: | 31 March 2024 |
| Contract Start Date: | 31 March 2024 |
View Original Notice
Access the full notice on the official portal
🤝 Need a consortium or subcontracting partner?
SMEs & Primes team up to win opportunities like this. Find partners on the board.
Awarded to
| Award value: | £3,891,000 |
| Award decision date: | 23 October 2024 |
| Award status: | Active |
A MOU has been put in place between NHS England and NICE. The NICE Managed Access team will work in partnership with NHS England Medicines Value ad Access directorate to successfully deliver the managed access schemes ( cancer drug fund and innovative medicines fund). This has been procured through Regulation 12(7).
Published contracts in the last 12 months
2,046
total contracts
£179666.3m
total value
£251,986,446
average contract size
Typical categories
Pipeline status
Not addedImports the contract into your BidWriter pipeline · Qualify before you commit to bid
Application Deadline
31 March 2024
Closed
Estimated Value
£3,891,000
Need help writing this bid?
Our specialists write winning tender responses. Free consultation, no obligation.
Book a free consultation →| Contract End Date: |
| 31 March 2027 |
| Contract Duration: | 3.0 years |
| Procurement ID (OCID): | ocds-b5fd17-25b3d21a-272a-4662-964f-80ef5381106f |
| Notice Reference: | 36bab920-2b30-4c49-9898-1db5b98299ee-806691 |